Medigen Biotechnology Corp. (3176.TWO)
TWD 27.8
(2.96%)
TWD 27.8
(2.96%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.15 Billion TWD | 9.64% |
| 2022 | 1.05 Billion TWD | -73.09% |
| 2021 | 3.92 Billion TWD | 538.8% |
| 2020 | 614.17 Million TWD | 11.19% |
| 2019 | 552.34 Million TWD | 35.61% |
| 2018 | 407.3 Million TWD | -4.72% |
| 2017 | 427.47 Million TWD | 6.9% |
| 2016 | 399.89 Million TWD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 354.1 Million TWD | 40.9% |
| 2024 Q1 | 251.31 Million TWD | -32.26% |
| 2023 Q3 | 416.88 Million TWD | 102.8% |
| 2023 FY | 1.15 Billion TWD | 9.64% |
| 2023 Q1 | 164.24 Million TWD | -19.37% |
| 2023 Q4 | 371.02 Million TWD | -11.0% |
| 2023 Q2 | 205.56 Million TWD | 25.16% |
| 2022 Q1 | 484.71 Million TWD | -77.73% |
| 2022 FY | 1.05 Billion TWD | -73.09% |
| 2022 Q4 | 203.7 Million TWD | 15.77% |
| 2022 Q3 | 175.96 Million TWD | -8.15% |
| 2022 Q2 | 191.56 Million TWD | -60.48% |
| 2021 Q3 | 1.38 Billion TWD | 0.0% |
| 2021 FY | 3.92 Billion TWD | 538.8% |
| 2021 Q4 | 2.17 Billion TWD | 57.15% |
| 2020 FY | 614.17 Million TWD | 11.19% |
| 2019 FY | 552.34 Million TWD | 35.61% |
| 2018 FY | 407.3 Million TWD | -4.72% |
| 2017 FY | 427.47 Million TWD | 6.9% |
| 2016 FY | 399.89 Million TWD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Sagittarius Life Science Corp | 440.46 Million TWD | -162.843% |
| Neith Corporation | 39.9 Million TWD | -2801.336% |
| TaiRx, Inc. | 5.08 Million TWD | -22680.795% |
| BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | -953.354% |
| Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | -12055.817% |
| Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | -23770.515% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | -3.861% |
| NeoCore Technology Co., Ltd. | 64.72 Million TWD | -1688.565% |
| GeneReach Biotechnology Corp. | 225.46 Million TWD | -413.492% |
| Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | -192.249% |
| Visgeneer Inc. | 147.99 Million TWD | -682.275% |
| Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 31.455% |
| G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | -538.063% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -4990.669% |
| Enimmune corporation | 43.49 Million TWD | -2561.792% |
| EirGenix Inc. | 1.02 Billion TWD | -13.208% |
| BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | -337.333% |
| Sunny Pharmtech Inc. | 428.82 Million TWD | -169.974% |
| Feng Chi Biotech Corp. | 180.57 Million TWD | -541.119% |
| Lukas Biomedical Inc. | 231.83 Million TWD | -399.377% |
| RBC Bioscience Corporation | 172.46 Million TWD | -571.27% |
| BiOptic Inc. | 228.26 Million TWD | -407.174% |
| Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -158927.473% |
| Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 36.984% |
| Mycenax Biotech Inc. | 652.62 Million TWD | -77.396% |
| Medigen Vaccine Biologics Corporation | 389.62 Million TWD | -197.138% |
| Bio Preventive Medicine Corp. | 1.2 Million TWD | -95737.748% |
| Level Biotechnology Inc. | 660.61 Million TWD | -75.25% |
| TaiMed Biologics Inc. | 491.77 Million TWD | -135.416% |
| GlycoNex Incorporation | 2.54 Million TWD | -45443.666% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | -266.386% |
| SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | -5632.422% |
| Lin BioScience, Inc. | - TWD | -Infinity% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -1286255.556% |
| VBI | 55.85 Million TWD | -1972.798% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
| NaviFUS Corp. | 22.48 Million TWD | -5049.771% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | -720.054% |
| Sinew Pharma Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -143716.149% |
| Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | -44.623% |
| Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | -1934.085% |
| AP Biosciences Inc | 32.25 Million TWD | -3489.496% |
| 3D Global Biotech Inc. | 20.63 Million TWD | -5511.011% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | -268.114% |
| Intech Biopharm Corporation | 25.84 Million TWD | -4379.127% |
| Oneness Biotech Co., Ltd. | 86.78 Million TWD | -1234.04% |
| Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
| TWi Biotechnology, Inc. | - TWD | -Infinity% |
| Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | -52.655% |
| TCI GENE Inc. | 333.85 Million TWD | -246.773% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -6431677.778% |
| Senhwa Biosciences, Inc. | 1 Million TWD | -115672.0% |
| Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | -1254.534% |
| NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | -622.933% |
| PharmaEngine, Inc. | 767.66 Million TWD | -50.81% |
| Savior Lifetec Corporation | 1.05 Billion TWD | -10.23% |
| TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | -840.211% |
| OBI Pharma, Inc. | 41.54 Million TWD | -2686.397% |
| Meribank Biotech Co., Ltd | 234.34 Million TWD | -394.03% |
| Acepodia, Inc. | 16.59 Million TWD | -6877.159% |
| Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | -2873.698% |